Here we find that an increase in the percentage of BTLA+CD4+ T cells is much higher in the patients that develop subsequent nosocomial infections, thus implicating BTLA as a possible biomarker for identifying which critically ill patients are most susceptible to the development of sepsis. This evidence concerns the gene BTLA and nosocomial infection.